UNSPSC 51143502: Carbidopa/levodopa

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN500. This VA Drug Class (CN500) classifies this compound as belonging to the group ANTIPARKINSON AGENTS.

UNSPSC 51143502 Carbidopa/levodopa is a Commodity code for a specific pharmaceutical product used in Parkinson's disease treatment, but the recent state and local procurement activity tagged to this code does not reflect purchases of the drug itself. Instead, the sole recent opportunity on record involves emergency response supplies — Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, a procurement entirely outside the scope of carbidopa/levodopa pharmaceutical distribution. The mismatch suggests either a data-entry error in the source or a significant misalignment between the code's nominal definition and how it is being applied in practice. State and local health departments and county agencies would be the expected issuing bodies for carbidopa/levodopa procurement, typically through cooperative purchasing vehicles or standing pharmaceutical supply contracts, but no such activity appears in the recent-opportunities record.

The geographic and temporal scope is too narrow to characterize meaningful opportunity volume under this code. Seminole County's naloxone solicitation, posted June 30, 2026 with a response deadline of July 26, 2023 (an apparent date error in the source), is the only recent opportunity tagged to this Commodity code and is unrelated to carbidopa/levodopa. Without additional state or local pharmaceutical procurement notices aligned to the code's actual scope, no reliable assessment of issuing-body concentration, geographic activity, or market demand can be made. Business development professionals should verify whether this code is actively used in their target jurisdictions for legitimate carbidopa/levodopa purchases or whether it represents a data classification issue requiring correction at the source.